In line, our data showed that ABAT is not repressed by methylation, but it is in fact hypomethylated throughout its entire TRR and overexpressed in ACP samples from cluster ACP-B, what could render mitochondrial metabolic advantages for tumor proliferation and disease recurrence in these patients. The gene discussed is NDUFAB1; the disease is neoplasm.